Showing 1 - 2 results of 2 for search 'Mads Haugland Haugen', query time: 0.01s Refine Results
  1. 1
    miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer

    miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer by Evita Maria Lindholm, Miriam Ragle Aure, Mads Haugland Haugen, Kristine Kleivi Sahlberg, Vessela N. Kristensen, Daniel Nebdal, Anne‐Lise Børresen‐Dale, Ole Christian Lingjærde, Olav Engebraaten

    Published 2019-10-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy

    High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy by Amadeo M. Parissenti, Laura B. Pritzker, Maria Aanesland Dahle, Hedda von der Lippe Gythfeldt, Twinkle Masilamani, Gabriel Theriault, Renée St-Onge, Lavina D’costa, Ole Christian Lingjaerde, Mads Haugland Haugen, Olav Engebraaten

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: